Skip to main content
Thierry Jahan, MD, Oncology, San Francisco, CA, UCSF Medical Center

ThierryM.JahanMD

Oncology San Francisco, CA

Endocrine Cancer, Hematologic Oncology, Sarcoma

Professor of Medicine Thoracic Oncology UCSF-Helen Diller Family Comprehensive Cancer Center

Dr. Jahan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jahan's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1991 - 1994
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Internal Medicine/Kennamer Fellowship UCLA, 1990 - 1991
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 1987 - 1990
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1989 - 2025

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • America's Top Doctors Castle Connolly, 2008-2009
  • America's Top Doctors for Cancer Castle Connolly, 2007-2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • GO2 Foundation for Lung Cancer Recognizes the Lung Cancer Community at Simply the Best XV Virtual Gala
    GO2 Foundation for Lung Cancer Recognizes the Lung Cancer Community at Simply the Best XV Virtual GalaNovember 15th, 2020
  • International Mesothelioma Conference Will Kick off at UCLA
    International Mesothelioma Conference Will Kick off at UCLASeptember 19th, 2016
  • Novel Vaccine Added to Chemotherapy Improves Patient Outcomes in Mesothelioma
    Novel Vaccine Added to Chemotherapy Improves Patient Outcomes in MesotheliomaApril 15th, 2016

Professional Memberships

Other Languages

  • Spanish, French

Hospital Affiliations